Skip to main content

Alan Guttmacher, Francis Collins, Joe Peden

Premium
Alan Guttmacher last week became acting director at the National Human Genome Research Institute after former director Francis Collins officially stepped down.
 
After 15 years as director of the institute, Collins announced two months ago that he planned to leave NHGRI to dedicate some time to “writing, reflection, and exploration of other professional opportunities in the public or private sectors.”
 
Guttmacher is a pediatrician and medical geneticist. He has held leadership jobs at NHGRI for nearly a decade and has been deputy director for around six years.
 
Before he was deputy director, Guttmacher was NHGRI’s senior clinical advisor to the director and was director of the Office of Policy, Communications, and Education.
 
The National Institutes of Health will “conduct a broad search” for Collins’ replacement, NHGRI said but details of that search process remain to be finalized.
 
"NHGRI and its collaborators, both at the NIH and throughout the biomedical research community, are moving ahead with our historic efforts to understand the intricacies of the human genome and how it functions,” Guttmacher said in a statement.
 

 
StarLIMS has appointed Joe Peden as general manager of its new UK subsidiary. Peden will be responsible for growing business in that region “as well as contribute to corporate product development," the company said.
 
Peden has spent two decades in LIMS product development, marketing, sales and executive positions. Prior to joining StarLIMS, he was president and chief operating officer of Ardenno, a provider of collaborative knowledge management software solutions for research and development and was also senior director of marketing and product management for the informatics group at Thermo Fisher Scientific.

Filed under

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.